Synchronous colonic malignancy
Keywords:Abdominal discomfort, Caecum and descending colon, Bowel thickening, Adenocarcinoma, Chemotherapy
Synchronous colorectal neoplasias, defined as 2 or more primary tumors identified in the same patient and at the same time, are caused by common genetic and environmental factors. Since intraoperative palpation can miss up to 69% of the SN, currently, synchronous neoplastic lesions are usually diagnosed at a preoperative staging by colonoscopy or virtual colonoscopy; according to data from literature, 3% of the patients with SN are affected by different types of malignant lesions while 33-55% shows villous adenomas. Literature also confirms the presence of primitive synchronous cancers; malignant synchronous lesions are very rare, showing the following incidence: between 0,17% and 0.69% in case of 2-3 synchronous lesions, 0.19% in case of 4-5 synchronous lesions. The most voluminous synchronous cancer is called "first primitive" or "index" cancer. When the index cancer is located in the caecum, the incidence of left colon synchronous cancers is higher than when the index cancer is located in the left colon. Colorectal adenomas standard treatment is usually represented by endoscopic polypectomy; indeed only 5% of synchronous colorectal lesions require a surgical treatment.
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics. CA: A Cancer Journal for Clinicians. 2009;59(4):225-49.
Jessup JM, Menck HR, Fremgen A, Winchester DP. Diagnosing colorectal carcinoma: clinical and molecular approaches. CA: A Cancer Journal for Clinicians. 1997;47(2):70-92.
Peeters M, Haller DG, ALberts SR, Goldberg RM, Smith R. Therapy for early-stage colorectal cancer. Oncology. 1999;13(3):307-21.
AJCC Cancer Staging Manual. 2002. Available at: https://cancerstaging.org/ references-tools/ deskreferences/ Documents/ AJCC 6th EdCancer Staging Manual Part1.pdf
Greene FL, Stewart AK, Norton HJ, Cohen AM. A new TNM staging strategy for node-positive (stage III) colon cancer: an analysis of 50,042 patients. Annals of Surgery. 2002;236(4):416-21.
Hawk ET, Limburg PJ, Viner JL. Epidemiology and prevention of colorectal cancer,” Surgical Clinics of North America. 2002;82(5):905-41.
Fante R, Roncucci L, Gregorio CD, Tamassia MG, Losi L, Benatti P, et al. Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma. Cancer. 1996;77(10):2013-21,
Arenas RB, Fichera A, Mhoon D, Michelassi F. Incidence and therapeutic implications of synchronous colonic pathology in colorectal adenocarcinoma. Surgery. 1997;122(4):706-10.
Cunliffe WJ, Hasleton PS, Tweedle DEF, Schofield PF. “Incidence of synchronous and metachronous colorectal carcinoma,” British Journal of Surgery. 1984;71(12):941-3.
Brullet E, Montane JM, Bombardo J, Bonfill X, Nogue M, Bordas JM. Intraoperative colonoscopy in patients with colorectal cancer. British Journal of Surgery. 1992;79(12):1376-8.
Burns FJ. Synchronous and metachronous malignancies of the colon and rectum,” Diseases of the Colon and Rectum. 1998;23(8):578-9.
Langevin JM, Nivatvongs S. The true incidence of synchronous cancer of the large bowel. A prospective study,” American Journal of Surgery. 1984;147(3):330-3.
Neugut AI, Lautenbach E, Abi-Rached B, Forde KA. Incidence of adenomas after curative resection for colorectal cancer. American Journal of Gastroenterology. 1996;91(10):2096-8.
Passman MA, Pommier RF, Vetto JT. Synchronous colon primaries have the same prognosis as solitary colon cancers. Diseases of the Colon and Rectum. 1996;39(3):329-34.
Chen HS, Sheen-Chen SM. Synchronous and 'Early' metachronous colorectal adenocarcinoma: analysis of prognosis and current trends. Diseases of the Colon and Rectum. 2000;43(8):1093-9.
Yang J, Peng JY, Chen W. Synchronous Colorectal Cancers: A Review of Clinical Features, Diagnosis, Treatment, and Prognosis, Dig Surg. 2011;28:379-85.